A global, neutral platform for first-principles safety and effectiveness, advancing justified confidence and improving patient outcomes.
Healthcare innovation is advancing at an unprecedented pace. Artificial intelligence, combination products, cell & gene therapies, digital health technologies, advanced manufacturing, and other emerging innovations are transforming how medical products are developed, manufactured, regulated, delivered, and used.
At the same time, regulations, standards, guidance, and industry practices continue to evolve and accumulate. While these frameworks provide important safeguards, their growing complexity and fragmented implementation can unintentionally shift organizational focus toward siloed compliance activities rather than maintaining a clear connection to the fundamental objectives of safety and effectiveness.
Across the medical product industry, organizations often operate under many of the same regulations and standards, yet achieve very different levels of risk management effectiveness, decision quality, product safety and effectiveness, and patient outcomes.
The challenge extends across the healthcare ecosystem. Manufacturers, suppliers, regulators, healthcare providers, patients, researchers, payers, and other stakeholders may approach safety and effectiveness from different perspectives, disciplines, responsibilities, geographies, and incentives. Aligning these stakeholders around shared first principles and fundamental objectives can provide a common foundation for better decisions, collaboration, and continuous learning.
Real-world outcomes—including submission challenges, inspection findings, warning letters, recalls, recurring quality issues, and unexpected post-market events—can reveal gaps between compliance and an organization's actual capability to consistently make and execute sound safety and effectiveness decisions.
MPSEI is being established to help close these gaps, and to help organizations and ecosystem stakeholders maintain a clear line of sight from decisions, requirements, processes, controls, evidence, and lifecycle activities back to the ultimate objective: improving patient outcomes through safe and effective medical products.
Vision
To become the globally trusted neutral platform for advancing justified confidence in medical product safety and effectiveness through first-principles thinking, decision excellence, organizational proficiency, and ecosystem alignment and collaboration.
Mission
To advance the science and practice of first-principles safety and effectiveness by aligning ecosystem stakeholders around shared first principles and fundamental objectives, and fostering education, collaboration, research, capability and maturity improvement, continuous learning, and recognition of demonstrated organizational proficiency across the global medical product ecosystem.
MPSEI brings together stakeholders across the healthcare ecosystem to advance shared objectives through collaboration, shared learning, and co-created solutions.
MPSEI is represented as a neutral platform core. The seven stakeholder groups exchange evidence, learning, and shared objectives with the center; the model does not imply MPSEI controls those organizations.
Neutral core
MPSEI seeks to complement — not replace — existing organizations.
MPSEI believes that meaningful collaboration begins with alignment on first principles and fundamental objectives. By establishing common ground around safety, effectiveness, and patient outcomes, diverse stakeholders can more effectively navigate differences in disciplines, organizational responsibilities, regional practices, regulatory frameworks, standards, and healthcare systems.
From a global perspective, MPSEI seeks to foster shared understanding and practical alignment while respecting legitimate differences in local regulatory requirements, healthcare priorities, and implementation approaches.
Where missions and interests overlap, MPSEI welcomes opportunities for joint initiatives, co-sponsored programs, shared learning, and collaborative efforts that build on each organization's respective strengths across regions and jurisdictions.
MPSEI builds on decades of collective progress: regulatory leadership from FDA and global regulators; standards and best practices from AAMI, ISO, IEC, ASTM, and IMDRF; and collaboration and innovation from MDIC, professional societies, academia, and public-private partnerships. MPSEI contributes a first-principles perspective to that foundation.
Where common interests exist, MPSEI welcomes collaboration, co-sponsored initiatives, joint working groups, and shared educational programs that advance first-principles safety and effectiveness while avoiding unnecessary duplication of effort.
MPSEI was developed as a neutral nonprofit initiative following discussions with FDA leadership at the IMSC Conference about the Risk Management Maturity Model (RM3) initiative. The Medical Product Safety & Effectiveness Institute is incorporated as a 501(c)(3), and MPSEI is trademarked.
Together, we will continuously discover fundamental truths, understand cause-and-effect relationships, align stakeholders around shared fundamental objectives, and build, challenge, maintain, and improve justified confidence that a medical product is safe and effective.